These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 25227719)
1. Treatment resistant schizophrenia: a comprehensive survey of randomised controlled trials. Sinclair D; Adams CE BMC Psychiatry; 2014 Sep; 14():253. PubMed ID: 25227719 [TBL] [Abstract][Full Text] [Related]
2. Clozapine versus other atypical antipsychotics for schizophrenia. Asenjo Lobos C; Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Leucht S Cochrane Database Syst Rev; 2010 Nov; (11):CD006633. PubMed ID: 21069690 [TBL] [Abstract][Full Text] [Related]
3. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. Temmingh HS; Williams T; Siegfried N; Stein DJ Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011057. PubMed ID: 29355909 [TBL] [Abstract][Full Text] [Related]
4. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia. Barber S; Olotu U; Corsi M; Cipriani A Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365 [TBL] [Abstract][Full Text] [Related]
10. Risperidone versus other atypical antipsychotics for schizophrenia. Komossa K; Rummel-Kluge C; Schwarz S; Schmid F; Hunger H; Kissling W; Leucht S Cochrane Database Syst Rev; 2011 Jan; (1):CD006626. PubMed ID: 21249678 [TBL] [Abstract][Full Text] [Related]
11. New generation antipsychotics for first episode schizophrenia. Rummel C; Hamann J; Kissling W; Leucht S Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012 [TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
13. Olanzapine versus other atypical antipsychotics for schizophrenia. Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348 [TBL] [Abstract][Full Text] [Related]
14. Quetiapine versus other atypical antipsychotics for schizophrenia. Komossa K; Rummel-Kluge C; Schmid F; Hunger H; Schwarz S; Srisurapanont M; Kissling W; Leucht S Cochrane Database Syst Rev; 2010 Jan; (1):CD006625. PubMed ID: 20091600 [TBL] [Abstract][Full Text] [Related]
15. Quetiapine versus other atypical antipsychotics for schizophrenia. Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315 [TBL] [Abstract][Full Text] [Related]
16. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis. Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482 [TBL] [Abstract][Full Text] [Related]
17. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
18. Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia. Jones C; Hacker D; Meaden A; Cormac I; Irving CB; Xia J; Zhao S; Shi C; Chen J Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008712. PubMed ID: 30480760 [TBL] [Abstract][Full Text] [Related]